FWL Investment Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,347
Closed -$70.1K 255
2023
Q3
$70.1K Buy
+5,347
New +$97.9K 0.05% 70
2023
Q1
Sell
-5,347
Closed -$123K 182
2022
Q4
$123K Buy
+5,347
New +$123K 0.09% 62
2022
Q3
Sell
-10,347
Closed -$148K 71
2022
Q2
$148K Sell
10,347
-1,250
-11% -$21.1K 0.11% 43
2022
Q1
$219K Sell
11,597
-5,600
-33% -$109K 0.14% 44
2021
Q4
$321K Buy
+17,197
New +$355K 0.2% 42

Other funds holding TMCI

FWL Investment Management's TMCI Position: Q4 2023 in Review

FWL Investment Management sold out of Treace Medical Concepts (TMCI) in Q4 2023, closing a stake of 5,347 shares — an estimated $70.1K sold.

FWL Investment Management first reported a position in TMCI in Q4 2021 and held it in 5 quarters. The position peaked at $321K in Q4 2021. 127 funds tracked by Wall St. Rank hold TMCI as of Q4 2023.

  • FWL Investment Management reported no remaining Treace Medical Concepts position as of Q4 2023 after selling out during the quarter.
  • FWL Investment Management sold 5,347 Treace Medical Concepts shares in Q4 2023, an estimated $70.1K.
  • FWL Investment Management first reported a position in Treace Medical Concepts in Q4 2021 and held it in 5 quarters.
  • FWL Investment Management's Treace Medical Concepts position peaked at $321K in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2023.

Based on FWL Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.